Lurasidone Hydrochloride Tablet, Film Coated
Product Images NDC 70518-4117

6 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 70518-4117). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Lurasidone hydrochloride, illustrating its molecular framework including multiple rings and heteroatoms, connected to an HCl molecule.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A pharmacokinetic impact chart showing the fold change and 90% confidence intervals of various drugs on Lurasidone pharmacokinetics. The graph plots interacting drugs including Ketoconazole, Diltiazem, Rifampin, and Lithium with their effects on Cmax and AUC relative to Lurasidone alone, across a horizontal axis representing change magnitude and direction.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A horizontal error bar chart illustrating fold changes and 90% confidence intervals for pharmacokinetic parameters (Cmax, AUC, Ctrough) of various interacting drugs compared to when administered alone. The drugs include Digoxin 0.25 mg SD, Midazolam 5 mg SD, Ethinyl Estradiol, Norelgestromin, and Lithium 600 mg BID, with changes plotted along a scale from -1.0 to 1.0 relative to each interactive drug alone.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
A pharmacokinetic chart showing fold change and 90% confidence intervals for Lurasidone hydrochloride. The chart compares Cmax and AUC values across renal impairment (mild, moderate, severe), hepatic impairment (mild, moderate, severe), and population variables including gender (females) and race (Asian) relative to a reference group.*
FDA Label Image

Mm1 (Lurasidone HCl 40mg 70518 4117 00)

Mm1 (Lurasidone HCl 40mg 70518 4117 00)
Lurasidone hydrochloride 40 mg film-coated tablet label showing a quantity of 30 tablets. The label includes the generic and proprietary name, strength, NDC number (70518-4117-00), and mentions repackaging by RemedyRepack Inc. Storage instructions and manufacturer details for Dr. Reddy's in Shreveport, LA, are also visible.*
FDA Label Image

Mm2 (Lurasidone HCl 40mg 70518 4117 01)

Mm2 (Lurasidone HCl 40mg 70518 4117 01)
Label for Lurasidone HCl Tablet 40 mg, 30 count. The label shows this prescription drug is repackaged by RemedyRepack Inc., Indiana, PA, with storage instructions and a QR code. The original manufacturer listed is Dr. Reddy's, Shreveport, LA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.